Prof Roger

Knaggs

Medicolegal Implications

Details to be Announced

Karin

Cannons

Evidence based guidelines and formulary

This session will signpost guidance on prescribing for pain and look at how local regional and national formularies can guide, restrict and empower prescribing practice.

Martin

Galligan

Updates in Prescribing including the DPP Competency

This session will explore the introduction of the single competency framework and its impact on the prescribing curriculum.  We will also discuss the requirements of the Designated Prescribing Practitioner role and how to support the next generation of independent and supplementary prescribers.

Dr Emma

Briggs

Imbedding Education in Practice

This session will explore the introduction of the single competency framework and its impact on the prescribing curriculum.  We will also discuss the requirements of the Designated Prescribing Practitioner role and how to support the next generation of independent and supplementary prescribers.

Lloyd

Allen

Compliance & Concordance

Promoting concordance is a key element of all independent prescribing practise. However, more than half of medications prescribed are not taken properly or not taken at all. The reasons for a patient’s non-compliance with prescribed medication is complex but the factors that promote compliance are becoming more clearly understood. This presentation will consider these factors and look at the psychological impact of prescribing medication for our patients and reflect on the need for prescribers to think about the role they adopt when they prescribe.

Jackie

Walumbe

Consideration for Ethical Decision Making & Moral Injury

Decisions around prescribing and deprescribing for pain are often informed by complex and inter-relating factors. Prescribers have to consider a myriad of sometimes conflicting information and balance the risks and benefits of starting or discontinuing a medicine. I argue, that prescribing for patients with clinical and psychosocial complexity constitutes an ethical decision-making process and that clinicians may experience moral injury when faced with less straightforward cases. I will present a series of fictional clinical cases and guide participants through selected thought experiments to explore these issues and discuss potential ways to manage complex decision making. 

Louise

Trewern

The Lived Experience of Opioid Reduction

Details to be Announced

Dr Emma

Davies

Medical Trials & Tapering

Concerns have been expressed that the number of people receiving prescriptions for dependence forming medicines has significantly increased over the last 20 years, in the UK.Medicines which may be used to treat pain occupy the largest space in the discussion. Whilst much of the focus tends to be on reducing or stopping analgesic medicines, it is vital we also change how they are started. This session aims to provide some practical tips and advice for trialling analgesics, including how it fits with recent NICE guidance on the topic.It will also touch on setting up tapers as part of a holistic approach to prescribing and supporting people to gain the most from their medicines.

Diarmuid

Denneny

Psychological  Informed Approaches to Deprescribing 

Details to be Announced

Dr Gillian

Chumbley

Prescribing for the Patient with Acute and Complex Pain

Details to be Announced

Panel

Discussion

Maintaing Professional Skills & Knowledge Chaired by Felicia Cox

AHP Roles Professional Development